7 Dermatological Formulation and Transdermal Systems KENNETH A. WALTERS and KEITH R. BRAIN An-eX Analytical Services Ltd., Cardiff, Wales I. INTRODUCTION Over the past few…

1. Systematic reviews: theresearcher‟s perspective and theresearch question Edoardo Aromataris www.joannabriggs.edu.au 2. Questions for you• Where do you work? What settings?–…

Slide 1Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory Odette Cancer Centre Slide 2 Preview…

Slide 1Prospective study on the effect of an aminoacid-based formula in infants with cow’s milk allergy/intolerance and atopic dermatitis Niggemann Ped All Imm 2001; 12:78…

Page 1 Effets secondaires des ARV Cours IMEA Roland Landman Cours IMEA Roland Landman Page 2 Reasons for Discontinuation of the First HAART Regimen 862 ART-naïve patients…

1. Ustekinumab therapy efficacy in psoriasis patients previously treated with biologic drugs Wojciech Francuzik, Aleksandra Skłodowska Tutor: Prof. Zygmunt Adamski Dermatology…

1. AD W0IC CCl~rEG TI' CI ic da demon.r-+........+....-~ C~REG C controls hy e ensio(carvedHol phosphate) without affecting metabo ic arame e -.Extended-release Capsules…

1. Progressing Towards an Internationally Competitive R&D-Oriented Pharmaceutical CompanyDainippon Sumitomo PharmaMasayo Tada President and CEO 29th Annual J.P. Morgan…

Slide 1 Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven, Belgium On…

Slide 1 Atorvastatin Clinical Study Program Slide 2 Introduction - Atorvastatin Indications: Atorvastatin is indicated as an adjunct to diet to reduce TC, LDL-C, apo B and…